These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29467352)

  • 21. The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.
    Hong F; Si C; Gao P; Cederbaum AI; Xiong H; Lu Y
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):33-43. PubMed ID: 26363552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats.
    Czechowska G; Celinski K; Korolczuk A; Wojcicka G; Dudka J; Bojarska A; Reiter RJ
    J Physiol Pharmacol; 2015 Aug; 66(4):567-79. PubMed ID: 26348081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1.
    Kornek M; Raskopf E; Guetgemann I; Ocker M; Gerceker S; Gonzalez-Carmona MA; Rabe C; Sauerbruch T; Schmitz V
    J Hepatol; 2006 Sep; 45(3):370-6. PubMed ID: 16780996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats.
    Ramadan A; Afifi N; Yassin NZ; Abdel-Rahman RF; Abd El-Rahman SS; Fayed HM
    Chem Biol Interact; 2018 Jun; 289():109-118. PubMed ID: 29738702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-To.
    Chen YW; Tsai MY; Pan HB; Tseng HH; Hung YT; Chou CP
    PLoS One; 2014; 9(12):e114756. PubMed ID: 25490034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melatonin mitigates thioacetamide-induced hepatic fibrosis via antioxidant activity and modulation of proinflammatory cytokines and fibrogenic genes.
    Lebda MA; Sadek KM; Abouzed TK; Tohamy HG; El-Sayed YS
    Life Sci; 2018 Jan; 192():136-143. PubMed ID: 29180002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.
    Lukivskaya O; Patsenker E; Lis R; Buko VU
    Eur J Clin Invest; 2008 May; 38(5):317-25. PubMed ID: 18380797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deleterious effect of human umbilical cord blood mononuclear cell transplantation on thioacetamide-induced chronic liver damage in rats.
    Alvarez-Mercado AI; García-Mediavilla MV; Sánchez-Campos S; Abadía F; Sáez-Lara MJ; Cabello-Donayre M; Gil A; González-Gallego J; Fontana L
    Cell Transplant; 2009; 18(10):1069-79. PubMed ID: 19650975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin protects against thioacetamide-induced hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes.
    Wang ME; Chen YC; Chen IS; Hsieh SC; Chen SS; Chiu CH
    J Nutr Biochem; 2012 Oct; 23(10):1352-66. PubMed ID: 22221674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic vitamin C insufficiency aggravated thioacetamide-induced liver fibrosis in gulo-knockout mice.
    Kim JH; Jeong YJ; Hong JM; Kim HR; Kang JS; Lee WJ; Hwang YI
    Free Radic Biol Med; 2014 Feb; 67():81-90. PubMed ID: 24184603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive index of liver fibrosis induced by alcohol, thioacetamide and Schistosomal infection in mice.
    Hessien MH; El-Sharkawi IM; El-Barbary AA; El-Beltagy DM; Snyder N
    BMC Gastroenterol; 2010 Jun; 10():53. PubMed ID: 20515488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis.
    Abramovitch S; Sharvit E; Weisman Y; Bentov A; Brazowski E; Cohen G; Volovelsky O; Reif S
    Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(2):G112-20. PubMed ID: 25214398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of zedoary turmeric oil on P450 activities in rats with liver cirrhosis induced by thioacetamide.
    Cheng JJ; Yang NB; Wu L; Lin JL; Dai GX; Zhu JY
    Int J Clin Exp Pathol; 2014; 7(11):7854-62. PubMed ID: 25550825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of Solanum nigrum on thioacetamide-induced liver fibrosis in mice.
    Hsieh CC; Fang HL; Lina WC
    J Ethnopharmacol; 2008 Sep; 119(1):117-21. PubMed ID: 18606216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic effect of nano-encapsulated and nano-emulsion forms of carvacrol on experimental liver fibrosis.
    Hussein J; El-Banna M; Mahmoud KF; Morsy S; Abdel Latif Y; Medhat D; Refaat E; Farrag AR; El-Daly SM
    Biomed Pharmacother; 2017 Jun; 90():880-887. PubMed ID: 28437891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of carnosine against thioacetamide-induced liver cirrhosis in rat.
    Aydin AF; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Güllüoğlu M; Uysal M; Koçak-Toker N
    Peptides; 2010 Jan; 31(1):67-71. PubMed ID: 19958806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of kaerophyllin against liver fibrogenesis in rats.
    Lee TF; Lin YL; Huang YT
    Eur J Clin Invest; 2012 Jun; 42(6):607-16. PubMed ID: 22103576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel liver fibrosis model in Macaca fascicularis induced by thioacetamide.
    Matsuo M; Murata S; Hasegawa S; Hatada Y; Ohtsuka M; Taniguchi H
    Sci Rep; 2020 Feb; 10(1):2450. PubMed ID: 32051422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of thioacetamide-induced liver fibrosis/cirrhosis by sildenafil treatment.
    Said E; Said SA; Gameil NM; Ammar EM
    Can J Physiol Pharmacol; 2013 Dec; 91(12):1055-63. PubMed ID: 24289076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide.
    Sato M; Kakubari M; Kawamura M; Sugimoto J; Matsumoto K; Ishii T
    Biochem Pharmacol; 2000 Mar; 59(6):681-90. PubMed ID: 10677585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.